GeneOne Life Science, Inc. (KRX:011000)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,730.00
-285.00 (-9.45%)
Last updated: Jun 5, 2025

GeneOne Life Science Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Operating Revenue
37,19235,72040,20348,71838,70041,503
Upgrade
Other Revenue
000--0-
Upgrade
Revenue
37,19235,72040,20348,71838,70041,503
Upgrade
Revenue Growth (YoY)
-6.65%-11.15%-17.48%25.89%-6.75%0.63%
Upgrade
Cost of Revenue
47,72246,68748,08839,54130,05830,211
Upgrade
Gross Profit
-10,530-10,967-7,8859,1778,64211,292
Upgrade
Selling, General & Admin
19,03220,80426,62730,86721,49819,651
Upgrade
Research & Development
3,7083,5567,04312,14711,4418,396
Upgrade
Other Operating Expenses
511.09503.5432.8295.42223.23160.42
Upgrade
Operating Expenses
30,47532,07240,48349,37636,17029,821
Upgrade
Operating Income
-41,005-43,039-48,368-40,199-27,527-18,529
Upgrade
Interest Expense
-2,689-2,156-1,180-7,309-4,455-628.5
Upgrade
Interest & Investment Income
123.35125.18518.686,2161,538561.22
Upgrade
Currency Exchange Gain (Loss)
-764.85-248.79107.21278.954,361-2,424
Upgrade
Other Non Operating Income (Expenses)
-3,822-3,4333,5692,9589,6382,791
Upgrade
EBT Excluding Unusual Items
-48,158-48,751-45,353-38,056-16,445-18,230
Upgrade
Gain (Loss) on Sale of Investments
0.58-4.254.25---
Upgrade
Gain (Loss) on Sale of Assets
2.822.823.41.31-106.933.24
Upgrade
Asset Writedown
---32,309---
Upgrade
Other Unusual Items
----1,018-
Upgrade
Pretax Income
-48,155-48,753-77,655-38,054-15,534-18,226
Upgrade
Income Tax Expense
-261.54-216.19113.4595.79353.75421.99
Upgrade
Net Income
-47,893-48,537-77,768-38,150-15,888-18,648
Upgrade
Net Income to Common
-47,893-48,537-77,768-38,150-15,888-18,648
Upgrade
Shares Outstanding (Basic)
807978777460
Upgrade
Shares Outstanding (Diluted)
807978777460
Upgrade
Shares Change (YoY)
2.34%2.20%0.34%4.37%22.98%88.03%
Upgrade
EPS (Basic)
-600.37-610.85-1000.23-492.35-214.00-308.90
Upgrade
EPS (Diluted)
-600.52-611.00-1000.23-492.35-214.00-309.00
Upgrade
Free Cash Flow
-16,439-19,356-27,345-69,419-87,291-32,069
Upgrade
Free Cash Flow Per Share
-206.08-243.60-351.70-895.90-1175.77-531.20
Upgrade
Gross Margin
-28.31%-30.70%-19.61%18.84%22.33%27.21%
Upgrade
Operating Margin
-110.25%-120.49%-120.31%-82.51%-71.13%-44.65%
Upgrade
Profit Margin
-128.77%-135.88%-193.44%-78.31%-41.05%-44.93%
Upgrade
Free Cash Flow Margin
-44.20%-54.19%-68.02%-142.49%-225.56%-77.27%
Upgrade
EBITDA
-22,853-25,078-35,592-34,776-22,877-14,508
Upgrade
EBITDA Margin
-61.45%-70.21%-88.53%-71.38%-59.11%-34.96%
Upgrade
D&A For EBITDA
18,15217,96112,7765,4244,6504,021
Upgrade
EBIT
-41,005-43,039-48,368-40,199-27,527-18,529
Upgrade
EBIT Margin
-110.25%-120.49%-120.31%-82.51%-71.13%-44.65%
Upgrade
Advertising Expenses
-381.32196.96341.71194.45168.08
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.